We observed that FGF21/sTGFBR2 treatment in control and lipodystrophic LmnaADKO mice housed at thermoneutrality reduced circulating TAG and glucose 4 weeks posttransduction but did not improve insulin resistance in lipodystrophic mice. This evidence concerns the gene FGF21 and Insulin resistance.